Apart from allergies, it is also used to treat insomnia, nausea, and for sedating agitated or anxious patients
The peptide CDMO market, valued at approximately $4.14 billion in 2025, is forecast to reach $9.84 billion by 2031 at a compound annual growth rate of 15.5%
Supports digestion, appetite, and metabolic health
Delivered by injection, Luthione provides 1200 mg of reduced glutathione per vial
At Minimal, we prioritize a patient-centered approach to wellness, combining weight loss prescriptions with personalized fitness and nutrition guidance to foster lasting health improvements
Both compounds have half-lives suitable for once-weekly dosing: Tirzepatide: ~5-day half-life Retatrutide: ~6-day half-life (estimated from Phase 2 pharmacokinetic data) Best Peptides for Fat Loss: Where Do These Compounds Rank